Global RNA Modified Pseudouridine Supply, Demand and Key Producers, 2024-2030

Page: 116

Published Date: 26 Aug 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

RNA modified pseudouridine is a common form of RNA base modification. It is slightly different in structure from conventional uridine (Uridine, U), but plays an important role in biological function.

The global RNA Modified Pseudouridine market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

This report studies the global RNA Modified Pseudouridine demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for RNA Modified Pseudouridine, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of RNA Modified Pseudouridine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global RNA Modified Pseudouridine total market, 2019-2030, (USD Million)
Global RNA Modified Pseudouridine total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: RNA Modified Pseudouridine total market, key domestic companies, and share, (USD Million)
Global RNA Modified Pseudouridine revenue by player, revenue and market share 2019-2024, (USD Million)
Global RNA Modified Pseudouridine total market by Type, CAGR, 2019-2030, (USD Million)
Global RNA Modified Pseudouridine total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global RNA Modified Pseudouridine market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include YAMASA CORPORATION, Biosynth Carbosynth, TriLink BioTechnologies, MP Biomedicals, Inc, Thermo Scientific Chemicals, BOC Sciences, Toronto Research Chemical, Wuhan Glycogene, Fine Biotech, Shanghai Hongene Biotech, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world RNA Modified Pseudouridine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global RNA Modified Pseudouridine Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global RNA Modified Pseudouridine Market, Segmentation by Type
    Solution
    Powder

Global RNA Modified Pseudouridine Market, Segmentation by Application:
    mRNA Vaccines
    Gene Expression and Therapy
    Other

Companies Profiled:
    YAMASA CORPORATION
    Biosynth Carbosynth
    TriLink BioTechnologies
    MP Biomedicals, Inc
    Thermo Scientific Chemicals
    BOC Sciences
    Toronto Research Chemical
    Wuhan Glycogene
    Fine Biotech
    Shanghai Hongene Biotech
    Biori

Key Questions Answered
1. How big is the global RNA Modified Pseudouridine market?
2. What is the demand of the global RNA Modified Pseudouridine market?
3. What is the year over year growth of the global RNA Modified Pseudouridine market?
4. What is the total value of the global RNA Modified Pseudouridine market?
5. Who are the Major Players in the global RNA Modified Pseudouridine market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 RNA Modified Pseudouridine Introduction
    1.2 World RNA Modified Pseudouridine Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World RNA Modified Pseudouridine Total Market by Region (by Headquarter Location)
        1.3.1 World RNA Modified Pseudouridine Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Based Company RNA Modified Pseudouridine Revenue (2019-2030)
        1.3.3 China Based Company RNA Modified Pseudouridine Revenue (2019-2030)
        1.3.4 Europe Based Company RNA Modified Pseudouridine Revenue (2019-2030)
        1.3.5 Japan Based Company RNA Modified Pseudouridine Revenue (2019-2030)
        1.3.6 South Korea Based Company RNA Modified Pseudouridine Revenue (2019-2030)
        1.3.7 ASEAN Based Company RNA Modified Pseudouridine Revenue (2019-2030)
        1.3.8 India Based Company RNA Modified Pseudouridine Revenue (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 RNA Modified Pseudouridine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Major Market Trends

2 Demand Summary
    2.1 World RNA Modified Pseudouridine Consumption Value (2019-2030)
    2.2 World RNA Modified Pseudouridine Consumption Value by Region
        2.2.1 World RNA Modified Pseudouridine Consumption Value by Region (2019-2024)
        2.2.2 World RNA Modified Pseudouridine Consumption Value Forecast by Region (2025-2030)
    2.3 United States RNA Modified Pseudouridine Consumption Value (2019-2030)
    2.4 China RNA Modified Pseudouridine Consumption Value (2019-2030)
    2.5 Europe RNA Modified Pseudouridine Consumption Value (2019-2030)
    2.6 Japan RNA Modified Pseudouridine Consumption Value (2019-2030)
    2.7 South Korea RNA Modified Pseudouridine Consumption Value (2019-2030)
    2.8 ASEAN RNA Modified Pseudouridine Consumption Value (2019-2030)
    2.9 India RNA Modified Pseudouridine Consumption Value (2019-2030)

3 World RNA Modified Pseudouridine Companies Competitive Analysis
    3.1 World RNA Modified Pseudouridine Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global RNA Modified Pseudouridine Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for RNA Modified Pseudouridine in 2023
        3.2.3 Global Concentration Ratios (CR8) for RNA Modified Pseudouridine in 2023
    3.3 RNA Modified Pseudouridine Company Evaluation Quadrant
    3.4 RNA Modified Pseudouridine Market: Overall Company Footprint Analysis
        3.4.1 RNA Modified Pseudouridine Market: Region Footprint
        3.4.2 RNA Modified Pseudouridine Market: Company Product Type Footprint
        3.4.3 RNA Modified Pseudouridine Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
    4.1 United States VS China: RNA Modified Pseudouridine Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: RNA Modified Pseudouridine Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: RNA Modified Pseudouridine Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: RNA Modified Pseudouridine Consumption Value Comparison
        4.2.1 United States VS China: RNA Modified Pseudouridine Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: RNA Modified Pseudouridine Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based RNA Modified Pseudouridine Companies and Market Share, 2019-2024
        4.3.1 United States Based RNA Modified Pseudouridine Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies RNA Modified Pseudouridine Revenue, (2019-2024)
    4.4 China Based Companies RNA Modified Pseudouridine Revenue and Market Share, 2019-2024
        4.4.1 China Based RNA Modified Pseudouridine Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies RNA Modified Pseudouridine Revenue, (2019-2024)
    4.5 Rest of World Based RNA Modified Pseudouridine Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based RNA Modified Pseudouridine Companies, Headquarters (Province, Country)
        4.5.2 Rest of World Based Companies RNA Modified Pseudouridine Revenue (2019-2024)

5 Market Analysis by Type
    5.1 World RNA Modified Pseudouridine Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Solution
        5.2.2 Powder
    5.3 Market Segment by Type
        5.3.1 World RNA Modified Pseudouridine Market Size by Type (2019-2024)
        5.3.2 World RNA Modified Pseudouridine Market Size by Type (2025-2030)
        5.3.3 World RNA Modified Pseudouridine Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
    6.1 World RNA Modified Pseudouridine Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 mRNA Vaccines
        6.2.2 Gene Expression and Therapy
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World RNA Modified Pseudouridine Market Size by Application (2019-2024)
        6.3.2 World RNA Modified Pseudouridine Market Size by Application (2025-2030)
        6.3.3 World RNA Modified Pseudouridine Market Size Market Share by Application (2019-2030)

7 Company Profiles
    7.1 YAMASA CORPORATION
        7.1.1 YAMASA CORPORATION Details
        7.1.2 YAMASA CORPORATION Major Business
        7.1.3 YAMASA CORPORATION RNA Modified Pseudouridine Product and Services
        7.1.4 YAMASA CORPORATION RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 YAMASA CORPORATION Recent Developments/Updates
        7.1.6 YAMASA CORPORATION Competitive Strengths & Weaknesses
    7.2 Biosynth Carbosynth
        7.2.1 Biosynth Carbosynth Details
        7.2.2 Biosynth Carbosynth Major Business
        7.2.3 Biosynth Carbosynth RNA Modified Pseudouridine Product and Services
        7.2.4 Biosynth Carbosynth RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Biosynth Carbosynth Recent Developments/Updates
        7.2.6 Biosynth Carbosynth Competitive Strengths & Weaknesses
    7.3 TriLink BioTechnologies
        7.3.1 TriLink BioTechnologies Details
        7.3.2 TriLink BioTechnologies Major Business
        7.3.3 TriLink BioTechnologies RNA Modified Pseudouridine Product and Services
        7.3.4 TriLink BioTechnologies RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 TriLink BioTechnologies Recent Developments/Updates
        7.3.6 TriLink BioTechnologies Competitive Strengths & Weaknesses
    7.4 MP Biomedicals, Inc
        7.4.1 MP Biomedicals, Inc Details
        7.4.2 MP Biomedicals, Inc Major Business
        7.4.3 MP Biomedicals, Inc RNA Modified Pseudouridine Product and Services
        7.4.4 MP Biomedicals, Inc RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 MP Biomedicals, Inc Recent Developments/Updates
        7.4.6 MP Biomedicals, Inc Competitive Strengths & Weaknesses
    7.5 Thermo Scientific Chemicals
        7.5.1 Thermo Scientific Chemicals Details
        7.5.2 Thermo Scientific Chemicals Major Business
        7.5.3 Thermo Scientific Chemicals RNA Modified Pseudouridine Product and Services
        7.5.4 Thermo Scientific Chemicals RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Thermo Scientific Chemicals Recent Developments/Updates
        7.5.6 Thermo Scientific Chemicals Competitive Strengths & Weaknesses
    7.6 BOC Sciences
        7.6.1 BOC Sciences Details
        7.6.2 BOC Sciences Major Business
        7.6.3 BOC Sciences RNA Modified Pseudouridine Product and Services
        7.6.4 BOC Sciences RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 BOC Sciences Recent Developments/Updates
        7.6.6 BOC Sciences Competitive Strengths & Weaknesses
    7.7 Toronto Research Chemical
        7.7.1 Toronto Research Chemical Details
        7.7.2 Toronto Research Chemical Major Business
        7.7.3 Toronto Research Chemical RNA Modified Pseudouridine Product and Services
        7.7.4 Toronto Research Chemical RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Toronto Research Chemical Recent Developments/Updates
        7.7.6 Toronto Research Chemical Competitive Strengths & Weaknesses
    7.8 Wuhan Glycogene
        7.8.1 Wuhan Glycogene Details
        7.8.2 Wuhan Glycogene Major Business
        7.8.3 Wuhan Glycogene RNA Modified Pseudouridine Product and Services
        7.8.4 Wuhan Glycogene RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Wuhan Glycogene Recent Developments/Updates
        7.8.6 Wuhan Glycogene Competitive Strengths & Weaknesses
    7.9 Fine Biotech
        7.9.1 Fine Biotech Details
        7.9.2 Fine Biotech Major Business
        7.9.3 Fine Biotech RNA Modified Pseudouridine Product and Services
        7.9.4 Fine Biotech RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Fine Biotech Recent Developments/Updates
        7.9.6 Fine Biotech Competitive Strengths & Weaknesses
    7.10 Shanghai Hongene Biotech
        7.10.1 Shanghai Hongene Biotech Details
        7.10.2 Shanghai Hongene Biotech Major Business
        7.10.3 Shanghai Hongene Biotech RNA Modified Pseudouridine Product and Services
        7.10.4 Shanghai Hongene Biotech RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Shanghai Hongene Biotech Recent Developments/Updates
        7.10.6 Shanghai Hongene Biotech Competitive Strengths & Weaknesses
    7.11 Biori
        7.11.1 Biori Details
        7.11.2 Biori Major Business
        7.11.3 Biori RNA Modified Pseudouridine Product and Services
        7.11.4 Biori RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Biori Recent Developments/Updates
        7.11.6 Biori Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 RNA Modified Pseudouridine Industry Chain
    8.2 RNA Modified Pseudouridine Upstream Analysis
    8.3 RNA Modified Pseudouridine Midstream Analysis
    8.4 RNA Modified Pseudouridine Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World RNA Modified Pseudouridine Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Table 2. World RNA Modified Pseudouridine Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
 Table 3. World RNA Modified Pseudouridine Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
 Table 4. World RNA Modified Pseudouridine Revenue Market Share by Region (2019-2024), (by Headquarter Location)
 Table 5. World RNA Modified Pseudouridine Revenue Market Share by Region (2025-2030), (by Headquarter Location)
 Table 6. Major Market Trends
 Table 7. World RNA Modified Pseudouridine Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
 Table 8. World RNA Modified Pseudouridine Consumption Value by Region (2019-2024) & (USD Million)
 Table 9. World RNA Modified Pseudouridine Consumption Value Forecast by Region (2025-2030) & (USD Million)
 Table 10. World RNA Modified Pseudouridine Revenue by Player (2019-2024) & (USD Million)
 Table 11. Revenue Market Share of Key RNA Modified Pseudouridine Players in 2023
 Table 12. World RNA Modified Pseudouridine Industry Rank of Major Player, Based on Revenue in 2023
 Table 13. Global RNA Modified Pseudouridine Company Evaluation Quadrant
 Table 14. Head Office of Key RNA Modified Pseudouridine Players
 Table 15. RNA Modified Pseudouridine Market: Company Product Type Footprint
 Table 16. RNA Modified Pseudouridine Market: Company Product Application Footprint
 Table 17. RNA Modified Pseudouridine Mergers & Acquisitions Activity
 Table 18. United States VS China RNA Modified Pseudouridine Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 19. United States VS China RNA Modified Pseudouridine Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 20. United States Based RNA Modified Pseudouridine Companies, Headquarters (States, Country)
 Table 21. United States Based Companies RNA Modified Pseudouridine Revenue, (2019-2024) & (USD Million)
 Table 22. United States Based Companies RNA Modified Pseudouridine Revenue Market Share (2019-2024)
 Table 23. China Based RNA Modified Pseudouridine Companies, Headquarters (Province, Country)
 Table 24. China Based Companies RNA Modified Pseudouridine Revenue, (2019-2024) & (USD Million)
 Table 25. China Based Companies RNA Modified Pseudouridine Revenue Market Share (2019-2024)
 Table 26. Rest of World Based RNA Modified Pseudouridine Companies, Headquarters (Province, Country)
 Table 27. Rest of World Based Companies RNA Modified Pseudouridine Revenue (2019-2024) & (USD Million)
 Table 28. Rest of World Based Companies RNA Modified Pseudouridine Revenue Market Share (2019-2024)
 Table 29. World RNA Modified Pseudouridine Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Table 30. World RNA Modified Pseudouridine Market Size Value by Type (2019-2024) & (USD Million)
 Table 31. World RNA Modified Pseudouridine Market Size by Type (2025-2030) & (USD Million)
 Table 32. World RNA Modified Pseudouridine Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Table 33. World RNA Modified Pseudouridine Market Size by Application (2019-2024) & (USD Million)
 Table 34. World RNA Modified Pseudouridine Market Size by Application (2025-2030) & (USD Million)
 Table 35. YAMASA CORPORATION Basic Information, Manufacturing Base and Competitors
 Table 36. YAMASA CORPORATION Major Business
 Table 37. YAMASA CORPORATION RNA Modified Pseudouridine Product and Services
 Table 38. YAMASA CORPORATION RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 39. YAMASA CORPORATION Recent Developments/Updates
 Table 40. YAMASA CORPORATION Competitive Strengths & Weaknesses
 Table 41. Biosynth Carbosynth Basic Information, Manufacturing Base and Competitors
 Table 42. Biosynth Carbosynth Major Business
 Table 43. Biosynth Carbosynth RNA Modified Pseudouridine Product and Services
 Table 44. Biosynth Carbosynth RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 45. Biosynth Carbosynth Recent Developments/Updates
 Table 46. Biosynth Carbosynth Competitive Strengths & Weaknesses
 Table 47. TriLink BioTechnologies Basic Information, Manufacturing Base and Competitors
 Table 48. TriLink BioTechnologies Major Business
 Table 49. TriLink BioTechnologies RNA Modified Pseudouridine Product and Services
 Table 50. TriLink BioTechnologies RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 51. TriLink BioTechnologies Recent Developments/Updates
 Table 52. TriLink BioTechnologies Competitive Strengths & Weaknesses
 Table 53. MP Biomedicals, Inc Basic Information, Manufacturing Base and Competitors
 Table 54. MP Biomedicals, Inc Major Business
 Table 55. MP Biomedicals, Inc RNA Modified Pseudouridine Product and Services
 Table 56. MP Biomedicals, Inc RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 57. MP Biomedicals, Inc Recent Developments/Updates
 Table 58. MP Biomedicals, Inc Competitive Strengths & Weaknesses
 Table 59. Thermo Scientific Chemicals Basic Information, Manufacturing Base and Competitors
 Table 60. Thermo Scientific Chemicals Major Business
 Table 61. Thermo Scientific Chemicals RNA Modified Pseudouridine Product and Services
 Table 62. Thermo Scientific Chemicals RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 63. Thermo Scientific Chemicals Recent Developments/Updates
 Table 64. Thermo Scientific Chemicals Competitive Strengths & Weaknesses
 Table 65. BOC Sciences Basic Information, Manufacturing Base and Competitors
 Table 66. BOC Sciences Major Business
 Table 67. BOC Sciences RNA Modified Pseudouridine Product and Services
 Table 68. BOC Sciences RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 69. BOC Sciences Recent Developments/Updates
 Table 70. BOC Sciences Competitive Strengths & Weaknesses
 Table 71. Toronto Research Chemical Basic Information, Manufacturing Base and Competitors
 Table 72. Toronto Research Chemical Major Business
 Table 73. Toronto Research Chemical RNA Modified Pseudouridine Product and Services
 Table 74. Toronto Research Chemical RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 75. Toronto Research Chemical Recent Developments/Updates
 Table 76. Toronto Research Chemical Competitive Strengths & Weaknesses
 Table 77. Wuhan Glycogene Basic Information, Manufacturing Base and Competitors
 Table 78. Wuhan Glycogene Major Business
 Table 79. Wuhan Glycogene RNA Modified Pseudouridine Product and Services
 Table 80. Wuhan Glycogene RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 81. Wuhan Glycogene Recent Developments/Updates
 Table 82. Wuhan Glycogene Competitive Strengths & Weaknesses
 Table 83. Fine Biotech Basic Information, Manufacturing Base and Competitors
 Table 84. Fine Biotech Major Business
 Table 85. Fine Biotech RNA Modified Pseudouridine Product and Services
 Table 86. Fine Biotech RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 87. Fine Biotech Recent Developments/Updates
 Table 88. Fine Biotech Competitive Strengths & Weaknesses
 Table 89. Shanghai Hongene Biotech Basic Information, Manufacturing Base and Competitors
 Table 90. Shanghai Hongene Biotech Major Business
 Table 91. Shanghai Hongene Biotech RNA Modified Pseudouridine Product and Services
 Table 92. Shanghai Hongene Biotech RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 93. Shanghai Hongene Biotech Recent Developments/Updates
 Table 94. Shanghai Hongene Biotech Competitive Strengths & Weaknesses
 Table 95. Biori Basic Information, Manufacturing Base and Competitors
 Table 96. Biori Major Business
 Table 97. Biori RNA Modified Pseudouridine Product and Services
 Table 98. Biori RNA Modified Pseudouridine Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 99. Biori Recent Developments/Updates
 Table 100. Biori Competitive Strengths & Weaknesses
 Table 101. Global Key Players of RNA Modified Pseudouridine Upstream (Raw Materials)
 Table 102. Global RNA Modified Pseudouridine Typical Customers


List of Figures
 Figure 1. RNA Modified Pseudouridine Picture
 Figure 2. World RNA Modified Pseudouridine Total Revenue: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World RNA Modified Pseudouridine Total Revenue (2019-2030) & (USD Million)
 Figure 4. World RNA Modified Pseudouridine Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Figure 5. World RNA Modified Pseudouridine Revenue Market Share by Region (2019-2030), (by Headquarter Location)
 Figure 6. United States Based Company RNA Modified Pseudouridine Revenue (2019-2030) & (USD Million)
 Figure 7. China Based Company RNA Modified Pseudouridine Revenue (2019-2030) & (USD Million)
 Figure 8. Europe Based Company RNA Modified Pseudouridine Revenue (2019-2030) & (USD Million)
 Figure 9. Japan Based Company RNA Modified Pseudouridine Revenue (2019-2030) & (USD Million)
 Figure 10. South Korea Based Company RNA Modified Pseudouridine Revenue (2019-2030) & (USD Million)
 Figure 11. ASEAN Based Company RNA Modified Pseudouridine Revenue (2019-2030) & (USD Million)
 Figure 12. India Based Company RNA Modified Pseudouridine Revenue (2019-2030) & (USD Million)
 Figure 13. RNA Modified Pseudouridine Market Drivers
 Figure 14. Factors Affecting Demand
 Figure 15. World RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
 Figure 16. World RNA Modified Pseudouridine Consumption Value Market Share by Region (2019-2030)
 Figure 17. United States RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
 Figure 18. China RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
 Figure 19. Europe RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
 Figure 20. Japan RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
 Figure 21. South Korea RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
 Figure 22. ASEAN RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
 Figure 23. India RNA Modified Pseudouridine Consumption Value (2019-2030) & (USD Million)
 Figure 24. Producer Shipments of RNA Modified Pseudouridine by Player Revenue ($MM) and Market Share (%): 2023
 Figure 25. Global Four-firm Concentration Ratios (CR4) for RNA Modified Pseudouridine Markets in 2023
 Figure 26. Global Four-firm Concentration Ratios (CR8) for RNA Modified Pseudouridine Markets in 2023
 Figure 27. United States VS China: RNA Modified Pseudouridine Revenue Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: RNA Modified Pseudouridine Consumption Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. World RNA Modified Pseudouridine Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Figure 30. World RNA Modified Pseudouridine Market Size Market Share by Type in 2023
 Figure 31. Solution
 Figure 32. Powder
 Figure 33. World RNA Modified Pseudouridine Market Size Market Share by Type (2019-2030)
 Figure 34. World RNA Modified Pseudouridine Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Figure 35. World RNA Modified Pseudouridine Market Size Market Share by Application in 2023
 Figure 36. mRNA Vaccines
 Figure 37. Gene Expression and Therapy
 Figure 38. Other
 Figure 39. World RNA Modified Pseudouridine Market Size Market Share by Application (2019-2030)
 Figure 40. RNA Modified Pseudouridine Industrial Chain
 Figure 41. Methodology
 Figure 42. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

YAMASA CORPORATION
Biosynth Carbosynth
TriLink BioTechnologies
MP Biomedicals, Inc
Thermo Scientific Chemicals
BOC Sciences
Toronto Research Chemical
Wuhan Glycogene
Fine Biotech
Shanghai Hongene Biotech
Biori

Related Reports

Global RNA Modified Pseudouridine Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global RNA Modified Pseudouridine Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 26 Aug 2024

date Medical Care

RNA modified pseudouridine is a common form of RNA base modification. It is slightly different in structure from conventional uridine (Uridine, U), but plays an important role in biological function.

Product Tags

RNA Modified Pseudouridine

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>